These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11449531)

  • 41. Low- and high-dose fluticasone propionate in asthma; effects during and after treatment.
    Gershman NH; Wong HH; Liu JT; Fahy JV
    Eur Respir J; 2000 Jan; 15(1):11-8. PubMed ID: 10678614
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A randomized, double-blind, double-dummy, parallel-group, multicenter, dose-reduction trial of the minimal effective doses of budesonide and fluticasone dry-powder inhalers in adults with mild to moderate asthma.
    Kuna P; Joubert JR; Greefhorst LA; Magnussen H
    Clin Ther; 2003 Aug; 25(8):2182-97. PubMed ID: 14512127
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adrenal suppression, evaluated by a low dose adrenocorticotropin test, and growth in asthmatic children treated with inhaled steroids.
    Kannisto S; Korppi M; Remes K; Voutilainen R
    J Clin Endocrinol Metab; 2000 Feb; 85(2):652-7. PubMed ID: 10690871
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma.
    Peden DB; Berger WE; Noonan MJ; Thomas MR; Hendricks VL; Hamedani AG; Mahajan P; House KW
    J Allergy Clin Immunol; 1998 Jul; 102(1):32-8. PubMed ID: 9679845
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 24 hour and fractionated profiles of adrenocortical activity in asthmatic patients receiving inhaled and intranasal corticosteroids.
    Wilson AM; Lipworth BJ
    Thorax; 1999 Jan; 54(1):20-6. PubMed ID: 10343626
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics of epimeric budesonide and fluticasone propionate after repeat dose inhalation--intersubject variability in systemic absorption from the lung.
    Minto C; Li B; Tattam B; Brown K; Seale JP; Donnelly R
    Br J Clin Pharmacol; 2000 Aug; 50(2):116-24. PubMed ID: 10930963
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of different inhaled combination therapies (EDICT): a randomised, double-blind comparison of Seretide (50/250 microg bd Diskus vs. formoterol (12 microg bd) and budesonide (800 microg bd) given concurrently (both via Turbuhaler) in patients with moderate-to-severe asthma.
    Ringdal N; Chuchalin A; Chovan L; Tudoric N; Maggi E; Whitehead PJ;
    Respir Med; 2002 Nov; 96(11):851-61. PubMed ID: 12418582
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
    Baumgarten C; Geldszus R; Behre U; Peslis N; Trautmann M;
    Eur J Med Res; 2002 Jan; 7(1):1-7. PubMed ID: 11827834
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients.
    Clark DJ; Grove A; Cargill RI; Lipworth BJ
    Thorax; 1996 Mar; 51(3):262-6. PubMed ID: 8779128
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term safety of fluticasone propionate and nedocromil sodium on bone in children with asthma.
    Roux C; Kolta S; Desfougères JL; Minini P; Bidat E
    Pediatrics; 2003 Jun; 111(6 Pt 1):e706-13. PubMed ID: 12777589
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A randomized, double-blind comparison of beclomethasone dipropionate extrafine aerosol and fluticasone propionate.
    Fairfax A; Hall I; Spelman R
    Ann Allergy Asthma Immunol; 2001 May; 86(5):575-82. PubMed ID: 11379810
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of fluticasone propionate and beclomethasone dipropionate on direct and indirect measurements of bronchial hyperresponsiveness in patients with stable asthma.
    Bootsma GP; Dekhuijzen PN; Festen J; Mulder PG; van Herwaarden CL
    Thorax; 1995 Oct; 50(10):1044-50. PubMed ID: 7491551
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A randomized, double-blind dose reduction study to compare the minimal effective dose of budesonide Turbuhaler and fluticasone propionate Diskhaler.
    Agertoft L; Pedersen S
    J Allergy Clin Immunol; 1997 Jun; 99(6 Pt 1):773-80. PubMed ID: 9215245
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparable effects of inhaled fluticasone propionate and budesonide on the HPA-axis in adult asthmatic patients.
    Ringdal N; Lundbäck B; Alton M; Rak S; Eivindson A; Bratten G; Kjaersgaard P
    Respir Med; 2000 May; 94(5):482-9. PubMed ID: 10868712
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fluticasone propionate hydrofluoroalkane inhalation aerosol in patients receiving inhaled corticosteroids.
    Lumry WR; Conway MM; LaForce CF; Pearlman DS; Scott CA; Herje NE; Wu WW; Crim C
    Ann Allergy Asthma Immunol; 2006 Jan; 96(1):51-9. PubMed ID: 16440533
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma concentrations of fluticasone propionate and budesonide following inhalation from dry powder inhalers by healthy and asthmatic subjects.
    Harrison TW; Tattersfield AE
    Thorax; 2003 Mar; 58(3):258-60. PubMed ID: 12612308
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fluticasone/formoterol dry powder versus budesonide/formoterol in adults and adolescents with uncontrolled or partly controlled asthma.
    Cukier A; Jacob CM; Rosario Filho NA; Fiterman J; Vianna EO; Hetzel JL; Neis MA; Fiss E; Castro FF; Fernandes AL; Stirbulov R; Pizzichini E;
    Respir Med; 2013 Sep; 107(9):1330-8. PubMed ID: 23849625
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical equivalence of salmeterol/fluticasone propionate in combination (50/100 microg twice daily) when administered via a chlorofluorocarbon-free metered dose inhaler or dry powder inhaler to patients with mild-to-moderate asthma.
    Bateman ED; Silins V; Bogolubov M
    Respir Med; 2001 Feb; 95(2):136-46. PubMed ID: 11217910
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and safety of ciclesonide once daily and fluticasone propionate twice daily in children with asthma.
    Pedersen S; Engelstätter R; Weber HJ; Hirsch S; Barkai L; Emeryk A; Weber H; Vermeulen J
    Pulm Pharmacol Ther; 2009 Jun; 22(3):214-20. PubMed ID: 19141327
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers.
    Chapman KR; Ringdal N; Backer V; Palmqvist M; Saarelainen S; Briggs M
    Can Respir J; 1999; 6(1):45-51. PubMed ID: 10202220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.